Virginia Tech® home

Archived Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition

Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC

Archived Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition

Date: Apr. 30, 2021
Time: 11:00 a.m. - 12:00 p.m.

About This Lecture

Epithelial-mesenchymal transition (EMT) is a normal differentiation process during development that enables epithelial cells to partially or completely repress epithelial junctions and reprogram gene expression, resulting in more motile and often more invasive cell behavior. EMT, which is generally thought of as a reversible process, allows the cells to reach new destinations and generate new cell populations. EMT is also repurposed pathologically during fibrosis and cancer progression, and allows carcinoma cells to disseminate, while additionally enabling the cells to acquire stem cell characteristics and cancer drug resistance. Studying the activities and signaling pathways of a secreted growth factor and cytokine, named transforming growth factor-beta (TGF-beta), it was shown a long time ago that TGF-beta can induce EMT. Consistent with this notion and its known activities, increased TGF-beta signaling is now seen as a driver of fibrosis and cancer dissemination that leads to metastasis. Dr. Dernyck's research highlights the cooperation of two signaling pathways, Smad signaling and Akt-mTOR signaling, in the progression and completion of EMT, and illustrates that prolonged exposure of cancer cells stabilizes EMT, which stands in contrast to the general notion that EMT is always reversible. When compared to reversible EMT, stabilized EMT has increased stem cell properties and cancer stem cell properties that depend on mTOR signaling. The recognition of the roles of EMT in fibrosis and cancer, and the key role of TGF-beta as driver of the EMT process allow for therapeutic opportunities.

Additional Details 

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. Presented virtually via Zoom primarily for research and clinical audiences, the lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

 

You May Also Be Interested In...

  • Home Item
    In Person Seminar: Sustaining Power: Building Energy Networks in Striated Muscles , home

    Sept. 22, 2023, 11:00 a.m. | Brian Glancy, Ph.D., Senior Investigator, Muscle Energetics Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research

  • Home Item
    Machine Learning and Human Thought - A Modern Frontier , home

    Sept. 28, 2023, 5:30 p.m. (Reception at 5 p.m.) | Read Montague, Ph.D., Virginia Tech Carilion Vernon Mountcastle Research Professor and Director, Center for Human Neuroscience Research, Fralin Biomedical Research Institute; Professor, Department of Physics, Virginia Tech College of Science | Maury Strauss Distinguished Public Lecture

  • Home Item
    In Person Seminar: Mitochondrial Ion Stress in Neurodegeneration , home

    Sept. 29, 2023, 11:00 a.m. | Xinnan Wang, M.D., Ph.D., Associate Professor, Neurosurgery, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research

  • Home Item
    In Person Seminar: Precision Medicine in Cardiac Electrophysiology , home

    Oct. 6, 2023, 11:00 a.m. | Jennifer Silva, M.D., Professor of Pediatrics and Pediatric Cardiology, Director of Pediatric Electrophysiology, Washington University School of Medicine in St. Louis; Jonathan Silva, Ph.D., Professor, Biomedical Engineering and Computer Science and Engineering, Washington University in St. Louis; and | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research

  • Home Item
    Cloudy with a Chance of Science: The Intersection of Wicked Problems, Perception, Communication, and Risk , home

    Oct. 19, 5:30 p.m. (Reception at 5 p.m.) | J. Marshall Shepherd, Ph.D., Georgia Athletic Association Distinguished Professor of Atmospheric Sciences and Geography, Director, UGA Atmospheric Sciences Program, University of Georgia, and Member, National Academy of Engineering, National Academy of Sciences, and American Academy of Arts and Sciences | Maury Strauss Distinguished Public Lecture

Rik Derynck, Ph.D.

Rik Derynck, Ph.D.

Professor, Department of Cell/Tissue Biology, and Department of Anatomy; Co-Director, UCSF Institute of Regeneration Medicine; Co-Director, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco